The effects of interferon (IFN) on the arachidonate metabolism and physiological functions of cultured endothelial cells and blood platelets have been examined. Cultured bovine aortic endothelial cells were found to be sensitive to the antiviral and antiproliferative activities of human leukocyte (alpha) IFN and to increase their capacity to synthesize prostacyclin (PGI2) upon exposure to IFN. Several observations indicate that IFN stimulates PGI2 synthesis at the level of the enzymes phospholipase A2 and cyclooxygenase: (a) PGI2 production was dependent upon the supply of exogenous arachidonic acid or the liberation of endogenous cellular arachidonate by ionophore A23187, but was not observed when IFN-treated cells were exposed to the endoperoxide prostaglandin H2. (b) IFN had no effect on the spontaneous release of PGI2 into the culture medium during the incubation period (24-72 h). (c) The stimulatory effect of IFN on PGI2 production was inhibited by both glucocorticoids and indomethacin. The effect of IFN on platelet prostaglandin metabolism was also investigated. Incubation of platelet-rich plasma with IFN had no effect on platelet aggregation and thromboxane A2 production. The biological significance of the findings presented in this paper may be considered in view of the protective role of PGI2 in the vessel wall and the fact that infection with certain viruses induces endothelial damage both in man and experimental animal models. (a) PGI2 production was dependent upon the supply of exogenous arachidonic acid or the liberation of endogenous cellular arachidonate by ionophore A23 187, but was not observed when IFN-treated cells were exposed to the endoperoxide prostaglandin H2. (b) IFN had no effect on the spontaneous release of PGI2 into the culture medium during the incubation period (24-72 h). (c) The stimulatory effect of IFN on PGI2 production was inhibited by both glucocorticoids and indomethacin. The effect of IFN on platelet prostaglandin metabolism was also investigated. Incubation of platelet-rich plasma with IFN had no effect on platelet aggregation and thromboxane A2 production. The biological significance of the findings presented in this paper may be considered in view of the protective role of PGI2 in the vessel wall and the fact that infection with certain viruses induces endothelial damage both in man and experimental animal models.
A bstract. The effects of interferon (IFN) on the arachidonate metabolism and physiological functions ofcultured endothelial cells and blood platelets have been examined. Cultured bovine aortic endothelial cells were found to be sensitive to the antiviral and antiproliferative activities of human leukocyte (a) IFN and to increase their capacity to synthesize prostacyclin (PGI2) upon exposure to IFN. Several observations indicate that IFN stimulates PGI2 synthesis at the level of the enzymes phospholipase A2 and cyclooxygenase: (a) PGI2 production was dependent upon the supply of exogenous arachidonic acid or the liberation of endogenous cellular arachidonate by ionophore A23 187, but was not observed when IFN-treated cells were exposed to the endoperoxide prostaglandin H2. (b) IFN had no effect on the spontaneous release of PGI2 into the culture medium during the incubation period (24-72 h). (c) The stimulatory effect of IFN on PGI2 production was inhibited by both glucocorticoids and indomethacin. The effect of IFN on platelet prostaglandin metabolism was also investigated. Incubation of platelet-rich plasma with IFN had no effect on platelet aggregation and thromboxane A2 production. The biological significance of the findings presented in this paper may be considered in view of the protective role of PGI2 in the vessel wall and the fact that infection with certain viruses induces endothelial damage both in man and experimental animal models.
Introduction
Endothelial cells line the inner surface ofblood vessels and form a protective barrier between the circulating blood and the vessel wall. In some patients, certain viral infections such as arboviruses (dengue virus), varicella, variola, and rubella lead to endothelial damage resulting in hemorrhagic manifestations or the formation of platelet thrombi at sites of damage (1) . The vascular endothelium has also been shown to be susceptible to viral infections in certain experimental models. Infection with SV40 virus results in endothelial transformation and impairment of its nonthrombogenic properties (2). Infection with Marek's disease herpes virus leads to the development of occlusive atherosclerosis in chickens (3) .
One of the protective mechanisms of the vessel wall against thrombosis and platelet deposition is the capacity of the endothelial cells to produce a unique prostaglandin (PG), prostacyclin (PGI2)' (4) . PGI2 is synthesized from arachidonic acid by the arterial wall and is a most potent vasodilator and inhibitor of platelet aggregation (4) . On the other hand, platelets produce thromboxane A2 (TXA2), which promotes platelet aggregation and functions as a potent vasoconstrictor (5) . Thus a balance between PGI2 and TXA2 is considered important in maintaining the vessel wall integrity.
During certain viral infections the endothelial cells are exposed to circulating interferon (IFN) induced by the virus (6) . IFN has been shown to stimulate production of prostaglandin E in human fibroblasts and a similar effect has also been observed with IFN-inducers such as poly (I): poly (C) and viruses (7) (8) (9) . The purpose of the present study was to examine whether IFN modulates the production of PGI2 by endothelial cells and of TXA2 by platelets, and hence affects the integrity of the vessel wall.
1. Abbreviations used in this paper: BAEC, bovine aortic endothelial cell; DME-H 16, Dulbecco's modified Eagle's medium; IFN, interferon; PG, prostaglandin; PGA, PGE2, PGF, and PGH2, prostaglandins A, E, F, and H; PGI2, prostacyclin; PRP, platelet-rich plasma; 6KF, 6- Platelet-rich plasma (PRP) was prepared by centrifugation of blood at 150 g for 10 min at room temperature and was kept tightly capped under 5% C02-95% air mixture until use. Platelet-poor plasma was prepared by centrifugation of PRP for 1 min in an Ependorf 5414 microfuge.
Platelet aggregation studies were performed using 0.4-ml aliquots of PRP stirred at 1,000 rpm at 370C in siliconized cuvettes in a Payton 800 aggregometer (Payton Associates, NY). The cell count in PRP was determined using a Coulter counter (Coulter Electronics, Inc.) and averaged 4 X 108 platelets/ml. PRP was incubated (room temperature, 1-24 h) in the presence or absence of IFN and then stirred in the aggregometer for 5 min, following which Hepes buffer and the aggregating agent were added in a total volume of 0.1 ml. Extent of aggregation was calculated as the percentage of the change in light transmission at 5 min after the addition ofthe stimulus relative to the full range between PRP and platelet-poor plasma. For determination of TXB2 levels, 0.1-ml aliquots were then withdrawn from the aggregation cuvette and quenched with 0.9 ml of 0.1 M phosphate-buffered saline containing l0-4 M indomethacin, and then frozen in liquid N2. Samples were stored in -70'C until assayed for TXB2 by a radioimmunoassay.
Quantitation ofPGs. PGI2 and TXA2 were quantitated in the culture medium or cell supernatants (following stimulation) by radioimmunoassays of their respective hydration products 6KF and TXB2 as previously described (15) . PGE2 was also quantitated in these fluids by radioimmunoassay (15) .
Statistical methods. Data were analyzed by the independent Student's t test and by one-way analysis of variance (Kruskall Wallis).
Results

Sensitivity of bovine aortic endothelial cells (BAEC) to IFN.
The sensitivity ofbovine cells to human IFN has been previously reported (16) . To establish the sensitivity of BAEC to human leukocyte IFN, we compared the IFN's protection against the cytopathic effect of VSV in BAEC and HeLa cells (Fig. 1) Effect ofIFN on PGI2 production. Confluent BAEC cultures were incubated with IFN, and both the accumulation of PGI2 spontaneously released into the culture medium and the stimulated production of PGI2 were evaluated. Fig. 3 shows an experiment performed with confluent BAEC cultures that were preincubated with IFN (1,000 U/ml) for 24 h. There was no increase in the spontaneous release of PGI2 into the medium when the cultures were treated with IFN. However, when the cells were exposed to exogenous arachidonic acid (20 MM, 2 min), a fourfold increase in PGI2 production was noted with FGF (100 ng/ml) was added to the cultures 24 h after seeding and every other day thereafter. At various times after seeding the cells were dissociated with STV and counted with a Coulter counter (Coulter Electronics, Inc.). Three culture dishes were used for each determination and the variation in different determinations did not exceed ±10% of the mean. (18) , also produced significantly higher amounts of PGI2 compared with untreated cells. In contrast, IFN had no effect on the production of PGI2 stimulated by incubation with the endoperoxide PGH2, which is a substrate for the enzyme PGI2 synthetase (19) . The IFN-mediated enhancement of PGI2 production was less pronounced when the cells were exposed to IFN for periods shorter than 24 h. Incubation with IFN for longer periods of time (up to 72 h) did not significantly increase the PGI2 production over the amounts found at 24 h (data not shown). The enhancement of the arachidonate-dependent PGI2 production was dependent on the concentration of IFN in a dose-response manner, and maximal stimulation was observed after treatment with 500-1,000 U/ml of IFN (Fig. 4) . Addition of FGF to the confluent endothelial cell cultures did not change the enhancing effect of IFN on the capacity of the cells to produce PGI2 (data not shown). Bovine endothelial cells have a limited capacity to produce TXA2 and PGE2 (15) . Preincubation with IFN did not result in a significant increase in the residual synthetic capacity of the cells for these PG (Fig. 4) .
The effect of IFN was also tested on subconfluent and not yet organized BAEC cultures where preincubation with IFN also resulted in the inhibition of cell proliferation, as shown in When IFN was replaced with mouse IFN, which does not induce antiviral activity in bovine cells (16) , no increase was observed in the PG12 production capacity of the BAEC (Table  I) . Preincubation of IFN at pH 2.5 did not affect its stimulatory effect on PGI2 production, while pretreatment with trypsin abolished this IFN activity (Table I) . These results suggest that the effect on BAEC is specific to IFN and is not due to contaminants.
Effect of inhibitors on PG synthesis. Hydrocortisone and dexamethasone, inhibitors of phospholipase A2, produced a significant inhibition (P < 0.01) of the enhanced synthesis of PG12 observed in IFN-treated BAEC. In contrast progesterone, which capacity upon exposure to both glucocorticoids. Indomethacin, a potent inhibitor of fatty acid cyclooxygenase, completely inhibited PGI2 production in both the control and IFN-treated cells (Fig. 5) . Effect of IFN on platelet aggregation and TXA2 formation. Since IFN stimulated PGI2 production by endothelial cells, it was of interest to investigate its effect on TXA2 production, in resting and stimulated platelets. As platelets are devoid of nuclei, possible effects of IFN are expected to directly affect their membrane. In fact, rapid effects of IFN occurring within 5 min of exposure to cells have been reported (20, 21) . Such activities of IFN may not require gene induction and thus nuclear involvement. Human platelets were incubated with IFN (500-5,000 U/ml, 370C) for up to 60 min, tested for aggregability, and aliquots were removed for determination of TXA2. The addition of IFN did not result in platelet aggregation nor were the levels of TXB2 measured at the end of 5 min of stirring different from those found with platelets not treated with IFN (Table II) . Preincubation (60 min, 220C) with IFN (103 U/ml) did not affect platelet aggregation or TXB2 production in either unstimulated platelets or platelets that were stimulated with either arachidonic acid (at subthreshold or aggregating concentrations), collagen, or ADP. The levels of TXB2 measured in PRP that was preincubated (at room temperature with gentle swirling) with 5,000 U/ml IFN for 24 h were not different from those observed in control PRP. These platelets were not responsive to the aggregating agents when tested after the 24-h incubation period. Similar results were observed with PRP obtained from five healthy donors, indicating that IFN has no effect on platelet reactivity and thromboxane production in vitro. PRP was incubated with and without IFN (5,000 U/ml, 60 min, 22°C) and then stirred in the aggregometer for another 5 min (37°C). Aggregation was recorded for S min after the addition of the aggregating agent or a control buffer (final volume 0.5 ml) and 0.1-ml aliquots were removed for TXB2 quantitation as detailed in Methods. Similar results were obtained with lower concentrations of IFN (500, 1,000, and 2,000 U/ml) and at incubation periods shorter than 60 min.
Discussion
The production of PGI2 by endothelial cells is regarded as one of the important mechanisms for preventing the deposition of platelets on the vessel wall (4, 18 (7, 9) . This difference between BAEC and fibroblasts may result from the lack of Av6-desaturase activity in endothelial cells (27) which therefore depend on the supply of exogenous arachidonic acid for PG synthesis. In contrast, fibroblasts that express this enzyme can convert linoleic acid into arachidonic acid (27) .
To elucidate the mechanism ofthe IFN-mediated stimulation of PGI2 synthesis in BAEC, different stimulators and inhibitors of the arachidonic acid cascade were tested. BAEC were stimulated with ionophore A23187, which activates the enzyme phospholipase A2, and with the endoperoxide PGH2, which is a substrate for the enzyme PGI2 synthetase ( 18, 19) . IFN-treated cells stimulated with the ionophore A23 187 appear to produce higher amounts of PGI2 compared with the untreated cells. However, IFN had no effect on the production of PGI2 when stimulated by the endoperoxide PGH2, suggesting that IFN does not stimulate the final enzymatic reaction in the synthesis of PGI2. Treatment with indomethacin, a potent inhibitor of cy-clooxygenase, resulted in a marked suppression of the arachidonate-induced PGI2 production in both the control and IFNtreated cells. The increased arachidonate-stimulated PGI2 production by IFN-treated BAEC was markedly suppressed by both hydrocortisone and dexamethasone, while the suppression of the basal synthesis of PGI2 by these glucocorticoids in cells not treated with IFN was less pronounced. Treatment with glucocorticoids primarily affects the lipolytic activity of phospholipase A2, which leads to the release of endogenous arachidonic acid from cellular lipids (28) . The finding that glucocorticoids inhibited PGI2 production in IFN-treated BAEC suggests that the exogenous arachidonic acid was first incorporated into membrane phospholipids and only then released by phospholipase A2 and converted to PGI2 by the cyclooxygenase. A similar phenomenon was described by Fuse et al. (9) who studied the effects of IFN on PGE synthesis in a fibroblast cell line GM258. They found that the IFN-mediated, increased production of PGE observed in the presence of exogenous arachidonic acid was almost completely inhibited by prednisolone, as compared with a smaller effect that glucocorticoids had on the basal production of PGE (9) . Schwartzman et al. (29), who studied PG production in the isolated perfused rabbit kidney, have also found that exogenous arachidonic acid is first equilibrated with a membrane phospholipid pool and that the newly synthesized PG originate mainly from esterified arachidonate and less from conversion of the free exogenous arachidonate.
Our observations and the findings reported by Fuse et al. (9) that glucocorticoids primarily suppress the stimulated PG production in the IFN-treated cells suggest that IFN mainly stimulates the activity of phospholipase A2. The results of experiments performed with other stimulators and inhibitors of the arachidonic acid cascade also support this conclusion. The finding that the expression of IFN enhancement of PG12 production requires preincubation for at least 24 h and the observations of Fuse et al. that cycloheximide and actinomycin D inhibit the effect of IFN on PGE synthesis by fibroblasts, suggest a nuclear involvement in these activities of IFN. These findings may explain the lack of IFN effect on TXA2 production by unstimulated or aggregating platelets, since, owing to the lack of nucleus, platelets are not capable of mRNA synthesis. However, IFN may possibly have an effect on platelet TXA2 synthetase at the level of the bone marrow megakaryocytes, since these nucleated cells can produce TXA2 (30).
The biological significance of the IFN-mediated enhanced capacity ofthe endothelial cells to produce PG12 requires further investigation in animals and man. It has been reported that PGs (PGA, PGE2) inhibit virus replication (31) and it is therefore possible that some of the antiviral activities of IFN are associated with PG's synthesis (30). Some support for this hypothesis may be derived from the finding that IFN-resistant mouse leukemia cell line was devoid of cyclooxygenase activity (32) . However, in the cultured endothelial cell system, the antiviral activity was observed at IFN concentrations lower than those required for the enhancement of PGI2 synthesis. Both IFN and PG are inhibitors ofcell proliferation (6, 33, 34) . The findings that similar concentrations of IFN are necessary for both the antiproliferative effect and the PG12 enhancing activity suggest that these two activities may be associated. The increased PGI2 production capacity may also be involved in inhibition of platelet deposition on subendothelial structures that may be exposed during virus infection.
